Stifel Financial
ROIV icon

Stifel Financial’s Roivant Sciences ROIV Stock Holding History

Stifel Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Buy
93,329
+3,790
+4% +$112K ﹤0.01% 1693
2026
Q1 		$2.48M Sell
89,539
-1,606
-2% -$41.3K ﹤0.01% 1800
2025
Q4 		$1.98M Buy
+91,145
New +$1.8M ﹤0.01% 1940
2025
Q2 		– Sell
-21,863
Closed -$221K – 3568
2025
Q1 		$221K Buy
+21,863
New +$236K ﹤0.01% 3138

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Stifel Financial's ROIV Position: Q2 2026 in Review

Stifel Financial increased its Roivant Sciences (ROIV) stake by 4.2% in Q2 2026, buying an estimated $112K and bringing the position to 93,329 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

Stifel Financial first reported a position in ROIV in Q1 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Stifel Financial held 93,329 shares of Roivant Sciences worth $3.3M as of Q2 2026.
  • Stifel Financial bought 3,790 Roivant Sciences shares in Q2 2026, an estimated $112K.
  • Roivant Sciences made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #1693 holding.
  • Stifel Financial first reported a position in Roivant Sciences in Q1 2025 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.